BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26974162)

  • 1. Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.
    Lasso P; Beltrán L; Guzmán F; Rosas F; Thomas MC; López MC; González JM; Cuéllar A; Puerta CJ
    PLoS One; 2016; 11(3):e0150996. PubMed ID: 26974162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of specific CD8+ T cells for a promiscuous epitope derived from Trypanosoma cruzi KMP-11 protein in chagasic patients.
    Lasso P; Mesa D; Cuéllar A; Guzmán F; Bolaños N; Rosas F; Velasco V; Thomas Mdel C; Lopez MC; Gonzalez JM; Puerta CJ
    Parasite Immunol; 2010 Jul; 32(7):494-502. PubMed ID: 20591120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of secondary anchor amino acid substitutions on the immunogenic properties of an HLA-A*0201-restricted T cell epitope derived from the Trypanosoma cruzi KMP-11 protein.
    Lasso P; Cárdenas C; Guzmán F; Rosas F; Thomas MC; López MC; González JM; Cuéllar A; Campanera JM; Luque FJ; Puerta CJ
    Peptides; 2016 Apr; 78():68-76. PubMed ID: 26854383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.
    Alvarez MG; Postan M; Weatherly DB; Albareda MC; Sidney J; Sette A; Olivera C; Armenti AH; Tarleton RL; Laucella SA
    PLoS Negl Trop Dis; 2008; 2(9):e288. PubMed ID: 18846233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of HLA-A∗02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients.
    Marañón C; Egui A; Carrilero B; Thomas MC; Pinazo MJ; Gascón J; Segovia M; López MC
    Microbes Infect; 2011 Nov; 13(12-13):1025-32. PubMed ID: 21704723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients.
    Egui A; Thomas MC; Morell M; Marañón C; Carrilero B; Segovia M; Puerta CJ; Pinazo MJ; Rosas F; Gascón J; López MC
    Mol Immunol; 2012 Oct; 52(3-4):289-98. PubMed ID: 22750229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.
    Sidney J; Southwood S; Sette A
    Immunogenetics; 2005 Jul; 57(6):393-408. PubMed ID: 16003466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of IFN-gamma production by CD8 T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi.
    Diez H; López MC; Del Carmen Thomas M; Guzmán F; Rosas F; Velazco V; González JM; Puerta C
    Parasite Immunol; 2006 Mar; 28(3):101-5. PubMed ID: 16441508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.
    Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF
    Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional supertype of HLA-A2 in the presentation of Flu matrix p58-66 to induce CD8+ T-cell response in a Northern Chinese population.
    Zhang HG; Pang XW; Shang XY; Xing Q; Chen WF
    Tissue Antigens; 2003 Oct; 62(4):285-95. PubMed ID: 12974795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.
    Burrows SR; Elkington RA; Miles JJ; Green KJ; Walker S; Haryana SM; Moss DJ; Dunckley H; Burrows JM; Khanna R
    J Immunol; 2003 Aug; 171(3):1407-12. PubMed ID: 12874232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients.
    Fonseca SG; Moins-Teisserenc H; Clave E; Ianni B; Nunes VL; Mady C; Iwai LK; Sette A; Sidney J; Marin ML; Goldberg AC; Guilherme L; Charron D; Toubert A; Kalil J; Cunha-Neto E
    Microbes Infect; 2005 Apr; 7(4):688-97. PubMed ID: 15848276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico.
    Villanueva-Lizama LE; Cruz-Chan JV; Aguilar-Cetina ADC; Herrera-Sanchez LF; Rodriguez-Perez JM; Rosado-Vallado ME; Ramirez-Sierra MJ; Ortega-Lopez J; Jones K; Hotez P; Bottazzi ME; Dumonteil E
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006240. PubMed ID: 29377898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel HLA-A*24:02-restricted adenovirus serotype 11-specific CD8+ T-cell epitope for adoptive immunotherapy.
    Imahashi N; Nishida T; Ito Y; Kawada J; Nakazawa Y; Toji S; Suzuki S; Terakura S; Kato T; Murata M; Naoe T
    Mol Immunol; 2013 Dec; 56(4):399-405. PubMed ID: 23911395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.
    Voutsas IF; Anastasopoulou EA; Tzonis P; Papamichail M; Perez SA; Baxevanis CN
    J Immunother Cancer; 2016; 4():75. PubMed ID: 27891225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of p53 peptides recognized by CD8(+) T lymphocytes from patients with bladder cancer.
    Ferriès E; Connan F; Pagès F; Gaston J; Hagnéré AM; Vieillefond A; Thiounn N; Guillet J; Choppin J
    Hum Immunol; 2001 Aug; 62(8):791-8. PubMed ID: 11476902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLAsupE: an integrated database of HLA supertype-specific epitopes to aid in the development of vaccines with broad coverage of the human population.
    Wang S; Guo L; Liu D; Liu W; Wu Y
    BMC Immunol; 2016 Jun; 17(1):17. PubMed ID: 27307005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
    Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
    Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.